Literature DB >> 2182539

Purification and characterization of an Escherichia coli Shiga-like toxin II variant.

D L MacLeod1, C L Gyles.   

Abstract

A Shiga-like toxin II variant was purified to homogeneity from Escherichia coli TB1(pCG6), which contained the toxin genes cloned in multicopy plasmid pUC18. The purification scheme involved polymyxin B extraction of the toxin from bacterial cells, followed by differential (NH4)2SO4 precipitation, anion- and cation-exchange fast-protein liquid chromatography, and immunoaffinity exclusion chromatography. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis of purified toxin revealed three protein bands that migrated with calculated molecular weights of 33,000, 27,500, and 7,500. These bands correspond to values for the A, A1, and B subunits, respectively, that would be expected on the basis of the nucleotide sequence and comparison with data for Shiga toxin and other Shiga-like toxins. Electrophoresis under nonreducing conditions resulted in disappearance of the 27,000-molecular-weight band. Western blot (immunoblot) analysis revealed three protein bands with molecular weights of 33,000, 27,500, and 7,500. The purified toxin induced typical signs of edema disease in pigs injected intravenously with doses as small as 3 ng/kg of body weight. The 50% cytotoxic doses for Vero, PK15, and Madin-Darby bovine and canine kidney cells were 0.5, 2.0, 8.0, and 8.0 pg, respectively. The 50% lethal dose of purified toxin for mice was 0.9 pg by the intraperitoneal route. Approximately 75 micrograms of purified toxin was required to induce a 1-ml/cm fluid response in rabbit ileal loops. Antiserum to the Shiga-like toxin II variant neutralized homologous toxin, Shiga-like toxin II, and Verotoxin 2 but not Shiga-like toxin I.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2182539      PMCID: PMC258614          DOI: 10.1128/iai.58.5.1232-1239.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  31 in total

1.  Nucleotide sequence of the Shiga-like toxin genes of Escherichia coli.

Authors:  S B Calderwood; F Auclair; A Donohue-Rolfe; G T Keusch; J J Mekalanos
Journal:  Proc Natl Acad Sci U S A       Date:  1987-07       Impact factor: 11.205

2.  Two distinct toxins active on Vero cells from Escherichia coli O157.

Authors:  S M Scotland; H R Smith; B Rowe
Journal:  Lancet       Date:  1985-10-19       Impact factor: 79.321

3.  Shigella dysenteriae 1 cytotoxin: periplasmic protein releasable by polymyxin B and osmotic shock.

Authors:  A Donohue-Rolfe; G T Keusch
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

4.  Cloning and sequencing of a Shiga-like toxin type II variant from Escherichia coli strain responsible for edema disease of swine.

Authors:  D L Weinstein; M P Jackson; J E Samuel; R K Holmes; A D O'Brien
Journal:  J Bacteriol       Date:  1988-09       Impact factor: 3.490

5.  Cloning and expression of the genes specifying Shiga-like toxin production in Escherichia coli H19.

Authors:  A Huang; S de Grandis; J Friesen; M Karmali; M Petric; R Congi; J L Brunton
Journal:  J Bacteriol       Date:  1986-05       Impact factor: 3.490

6.  Characterization of purified Shiga toxin from Shigella dysenteriae 1.

Authors:  T Yutsudo; T Honda; T Miwatani; Y Takeda
Journal:  Microbiol Immunol       Date:  1986       Impact factor: 1.955

7.  Vero cell toxins in Escherichia coli and related bacteria: transfer by phage and conjugation and toxic action in laboratory animals, chickens and pigs.

Authors:  H W Smith; P Green; Z Parsell
Journal:  J Gen Microbiol       Date:  1983-10

8.  Vero response to a cytotoxin of Escherichia coli.

Authors:  J Konowalchuk; J I Speirs; S Stavric
Journal:  Infect Immun       Date:  1977-12       Impact factor: 3.441

9.  Purification and characterization of a Shigella dysenteriae 1-like toxin produced by Escherichia coli.

Authors:  A D O'Brien; G D LaVeck
Journal:  Infect Immun       Date:  1983-05       Impact factor: 3.441

Review 10.  Infection by verocytotoxin-producing Escherichia coli.

Authors:  M A Karmali
Journal:  Clin Microbiol Rev       Date:  1989-01       Impact factor: 26.132

View more
  23 in total

1.  Inhibition of neutrophil apoptosis by verotoxin 2 derived from Escherichia coli O157:H7.

Authors:  J Liu; T Akahoshi; T Sasahana; H Kitasato; R Namai; T Sasaki; M Inoue; H Kondo
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Neutral red assay for measurement of quantitative vero cell cytotoxicity.

Authors:  A Valdivieso-Garcia; R C Clarke; K Rahn; A Durette; D L Macleod; C L Gyles
Journal:  Appl Environ Microbiol       Date:  1993-06       Impact factor: 4.792

3.  Identification and characterization of a newly isolated shiga toxin 2-converting phage from shiga toxin-producing Escherichia coli.

Authors:  M Watarai; T Sato; M Kobayashi; T Shimizu; S Yamasaki; T Tobe; C Sasakawa; Y Takeda
Journal:  Infect Immun       Date:  1998-09       Impact factor: 3.441

4.  A case-control study of verocytotoxigenic Escherichia coli infection in cats with diarrhea.

Authors:  K A Smith; S Kruth; J Hammermueller; C Gyles; J B Wilson
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

5.  Crystal structure of glycosylasparaginase from Flavobacterium meningosepticum.

Authors:  J Xuan; A L Tarentino; B G Grimwood; T H Plummer; T Cui; C Guan; P Van Roey
Journal:  Protein Sci       Date:  1998-03       Impact factor: 6.725

6.  Localization of potential binding sites for the edema disease verotoxin (VT2e) in pigs.

Authors:  T E Waddell; B L Coomber; C L Gyles
Journal:  Can J Vet Res       Date:  1998-04       Impact factor: 1.310

7.  Effectiveness of egg yolk antibody against shiga toxin II variant toxicity in vitro and in vivo.

Authors:  Yufei Feng; Wenxin Liu; Dongfang Shi
Journal:  Curr Microbiol       Date:  2013-05-21       Impact factor: 2.188

8.  Sodium deoxycholate facilitates systemic absorption of verotoxin 2e from pig intestine.

Authors:  T E Waddell; C L Gyles
Journal:  Infect Immun       Date:  1995-12       Impact factor: 3.441

9.  Mitomycin-induced synthesis of a Shiga-like toxin from enteropathogenic Escherichia coli H.I.8.

Authors:  A J Yee; S De Grandis; C L Gyles
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

10.  A case-control study of selected pathogens including verocytotoxigenic Escherichia coli in calf diarrhea on an Ontario veal farm.

Authors:  J B Wilson; S A McEwen; R C Clarke; K E Leslie; D Waltner-Toews; C L Gyles
Journal:  Can J Vet Res       Date:  1992-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.